001     181590
005     20240229145650.0
024 7 _ |a 10.1002/ijc.34253
|2 doi
024 7 _ |a pmid:36053839
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:134915690
|2 altmetric
037 _ _ |a DKFZ-2022-02093
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Mahamat-Saleh, Yahya
|b 0
245 _ _ |a Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC).
260 _ _ |a Bognor Regis
|c 2023
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1671445319_16478
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2023;152:348–362
520 _ _ |a Experimental evidence suggests that alcohol induces cutaneous carcinogenesis, yet epidemiological studies on the link between alcohol intake and skin cancer have been inconsistent. The European Prospective Investigation into Cancer and Nutrition (EPIC) is a prospective cohort initiated in 1992 in 10 European countries. Alcohol intake at baseline and average lifetime alcohol intake were assessed using validated country-specific dietary and lifestyle questionnaires. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated in Cox models. A total of 14 037 skin cancer cases (melanoma: n = 2457; basal-cell carcinoma (BCC): n = 8711; squamous-cell carcinoma (SCC): n = 1928; unknown: n = 941) were identified among 450 112 participants (average follow-up: 15 years). Baseline alcohol intake was positively associated with SCC (>15 vs 0.1-4.9 g/day: HR = 1.44, 95% CI = 1.17-1.77; Ptrend = .001), BCC (HR = 1.12, 95% CI = 1.01-1.23; Ptrend = .04), and melanoma risks in men (HR = 1.17, 95% CI = 0.95-1.44; Ptrend = .17), while associations were more modest in women (SCC: HR = 1.09, 95% CI = 0.90-1.30; Ptrend = .13; BCC: HR = 1.08, 95% CI = 1.00-1.17, Ptrend = .03; melanoma: HR = 0.93, 95% CI = 0.80-1.08, Ptrend = .13). Associations were similar for lifetime alcohol intake, with an attenuated linear trend. Lifetime liquor/spirit intake was positively associated with melanoma (fourth vs first quartile: HR = 1.47, 95% CI = 1.08-1.99; Ptrend = .0009) and BCC risks in men (HR = 1.17, 95% CI = 1.04-1.31; Ptrend = .14). Baseline and lifetime intakes of wine were associated with BCC risk (HR = 1.25 in men; HR = 1.11-1.12; in women). No statistically significant associations were found between beverage types and SCC risk. Intake of beer was not associated with skin cancer risk. Our study suggests positive relationships between alcohol intake and skin cancer risk, which may have important implications for the primary prevention of skin cancer.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a alcohol
|2 Other
650 _ 7 |a cohort studies
|2 Other
650 _ 7 |a cutaneous melanoma
|2 Other
650 _ 7 |a epidemiology
|2 Other
650 _ 7 |a keratinocyte cancers
|2 Other
700 1 _ |a Al-Rahmoun, Marie
|b 1
700 1 _ |a Severi, Gianluca
|b 2
700 1 _ |a Ghiasvand, Reza
|0 0000-0002-5466-7308
|b 3
700 1 _ |a Veierod, Marit B
|b 4
700 1 _ |a Caini, Saverio
|b 5
700 1 _ |a Palli, Domenico
|b 6
700 1 _ |a Botteri, Edoardo
|0 0000-0002-9023-8068
|b 7
700 1 _ |a Sacerdote, Carlotta
|0 0000-0002-8008-5096
|b 8
700 1 _ |a Ricceri, Fulvio
|0 0000-0001-8749-9737
|b 9
700 1 _ |a Lukic, Marko
|0 0000-0002-3608-9743
|b 10
700 1 _ |a Sánchez, Maria J
|b 11
700 1 _ |a Pala, Valeria
|0 0000-0001-5438-970X
|b 12
700 1 _ |a Tumino, Rosario
|b 13
700 1 _ |a Chiodini, Paolo
|b 14
700 1 _ |a Amiano, Pilar
|b 15
700 1 _ |a Colorado-Yohar, Sandra
|b 16
700 1 _ |a Chirlaque, María-Dolores
|b 17
700 1 _ |a Ardanaz, Eva
|b 18
700 1 _ |a Bonet, Catalina
|b 19
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 20
|u dkfz
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 21
|u dkfz
700 1 _ |a Schulze, Matthias B
|b 22
700 1 _ |a Overvad, Kim
|b 23
700 1 _ |a Dahm, Christina C
|b 24
700 1 _ |a Antoniussen, Christian S
|b 25
700 1 _ |a Tjønneland, Anne
|b 26
700 1 _ |a Kyrø, Cecilie
|0 0000-0002-9083-8960
|b 27
700 1 _ |a Bueno-de-Mesquita, Bas
|b 28
700 1 _ |a Manjer, Jonas
|0 0000-0002-3158-5289
|b 29
700 1 _ |a Jansson, Malin
|b 30
700 1 _ |a Esberg, Anders
|b 31
700 1 _ |a Mori, Nagisa
|0 0000-0003-1721-4083
|b 32
700 1 _ |a Ferrari, Pietro
|0 0000-0001-9358-7338
|b 33
700 1 _ |a Weiderpass, Elisabete
|0 0000-0003-2237-0128
|b 34
700 1 _ |a Boutron-Ruault, Marie-Christine
|0 0000-0002-5956-5693
|b 35
700 1 _ |a Kvaskoff, Marina
|0 0000-0002-4557-3772
|b 36
773 _ _ |a 10.1002/ijc.34253
|g p. ijc.34253
|0 PERI:(DE-600)1474822-8
|p 348–362
|t International journal of cancer
|v 152
|y 2023
|x 0020-7136
909 C O |p VDB
|o oai:inrepo02.dkfz.de:181590
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2022
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-02-04
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-04
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2022
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2022
|d 2023-10-21
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21